Page 117 - Annual report 2021-22
P. 117

Annual Report 2021-22 |


                   59. Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes. Sahana
                       S, Sivadas A, Mangla M, Jain A, Bhoyar RC, Pandhare  K,  Mishra A*, Sharma D, Imran  M,
                       Senthivel V, Divakar MK, Rophina M, Jolly B, Batra A, Sharma S, Siwach S, Jadhao AG, Palande
                       NV, Jha GN, Ashrafi N, Mishra PK*, Vidhya AK, Jain S, Dash D, Kumar NS, Vanlallawma A, Sarma
                       RJ, Chhakchhuak L, Kalyanaraman S, Mahadevan R, Kandasamy S, Devi P, Rajagopal RE, Ramya
                       JE, Devi PN, Bajaj A, Gupta V, Mathew S, Goswami S, Prakash S, Joshi K, Kumla M, Sreedevi S,    100
                       Gajjar D, Soraisham R, Yadav R, Devi YS, Gupta A, Mukerji M, Ramalingam S, Binukumar BK,
                       Sivasubbu S, Scaria V. PHARMACOGENOMICS;2021 JUL;10;22;603-618 [Journal Article]
                                                                                                      3.24
                   60. Genome and transcriptome analysis of the mealybug Maconellicoccus hirsutus: Correlation
                       with its unique phenotypes. Kohli S, Gulati P, Narang A, Maini J, Shamsudheen KV, Pandey R,
                       Scaria V, Sivasubbu S, Brahmachari V. GENOMICS;2021 JUL;4;113;2483-2494 [Journal Article]
                                                                                                      4.31
                   61. Symptomatic  reinfection  of  SARS-CoV-2  with  spike  protein  variant  N440K  associated  with
                       immune  escape.  Rani  PR,  Imran  M,  Lakshmi  JV,  Jolly  B,  Jain  A,  Surekha  A,  Senthivel  V,
                       Chandrasekhar P, Divakar MK, Srinivasulu D, Bhoyar RC, Vanaja PR, Scaria V, Sivasubbu S.
                       JOURNAL OF MEDICAL VIROLOGY;2021 JUL;7;93;4163-4165 [Letter]
                                                                                                      20.6
                   62. Self-Assembled Biodegradable Core-Shell Nanocomposites of Amphiphilic Retinoic Acid-LMW
                       bPEI Conjugates Exhibit Enhanced Transgene Expression in Hepatocellular Carcinoma Cells
                       With  Inherent  Anticancer  Properties.  Ahmadi  Z,  Jena  H,  Singh  M,  Dhawan  G,  Kumar  P.  J
                       PHARM SCI-US 2021 Aug;110(8):3047-3060. [Journal Article]
                                                                                                      3.43
                   63. Detection of Mycolic Acid Implying the Presence of Mycobacterium Tuberculosis H37Rv in
                       Host. Meena S, Singh S, Meena LS. SCH ACAD J BIOSC. 2021 Aug 9 (8):185-191 [Journal Article]
                                                                                                         3
                   64. Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent
                       Plasma in Severe COVID-19. Bandopadhyay P, D'Rozario R, Lahiri A, Sarif J, Ray Y, Paul SR, Roy
                       R, Maiti R, Chaudhuri K, Bagchi S, Maiti A, Perwez MM, Sarkar BS, Roy D,  Chakraborty R,
                       Vasudevan JS, Sharma S, Biswas D, Maiti C, Saha B, Bhattacharya P, Pandey R, Chatterjee S,
                       Paul  S,  Ganguly  D.  THE  JOURNAL  OF  INFECTIOUS  DISEASES;2021  AUG  16;4;224;565-574
                       [Randomized Controlled Trial]
                                                                                                     5.226
                   65. A comprehensive review of COVID-19 in India: A frequent catch of the information. Shivangi,
                       Meena LS. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY;2021 AUG;4;68;700-711 [Review]
                                                                                                     2.431
                   66. High-altitude pulmonary edema is aggravated by risk-loci and associated transcription factors
                       in HIF-prolyl hydroxylases. Sharma K, Aastha Mishra, Singh HN, Prashar D, Alam P, Thinlas T,
                       Mohammad G, Kukreti R, Syed MA, Pasha MAQ. Hum Mol Genet. 2021;30(18):1734-1749.
                       [Journal Article]
                                                                                                      6.15
                   67. CRISPR  Cas9  based  genome  editing  in  inherited  retinal  dystrophies.  Bansal  M,  Acharya  S,
                       Sharma  S,  Phutela  R,  Rauthan  R, Maiti  S,  Chakraborty  D.  Ophthalmic  Genet.  2021
                       Aug;42(4):365-374 [Review]
                                                                                                     1.803
   112   113   114   115   116   117   118   119   120   121   122